Andrew acts for claimants who have been exposed to asbestos and subsequently develop asbestos-related injuries, such as mesothelioma, asbestosis, lung cancer and pleural thickening. He also represents claimants with life changing industrial diseases, such as acute silicosis. Andrew has experience of complex catastrophic injury claims arising as a result of road traffic accidents and accidents at work.
Everything Andrew has done for us has been top rate. Nothing has ever been too much trouble. He has kept us informed about everything from day one. He has dealt with everything in a very professional and courteous manner. We have been very grateful to have had Andrew in our corner.
Client of Andrew
Andrew has successfully obtained compensation in a range of complex asbestos cases. He is focused on achieving results which suit clients’ individual circumstances. This includes obtaining interim payments of damages to allow clients to pay for private medical treatment and achieving settlements which allows them to continue to claim the costs of medical treatment in the future, including immunotherapy.
He has obtained settlements for clients with asbestosis and pleural thickening which allows them to return to court in the future if their condition deteriorates or they develop a more serious asbestos related condition.
Andrew qualified as a solicitor in September 2017. He developed a particular interest in industrial disease claims during the first seat of his training contract, which was in the personal injury department at Leigh Day.
Andrew obtained his undergraduate degree in law from the University of Kent and went on to obtain a master’s degree in law from University College London. He was awarded a distinction in his master’s degree which focused on UK Human Rights and Equality Law and Alternative Dispute Resolution.
Andrew is a member of the Association of Personal Injury Lawyers and holds accredited litigator status.
Andrew in the news
Annual mesothelioma deaths predicted to peak - an in-depth look by Andrew Cooper First published by LexisNexis 31.7.19
Mesothelioma claims. This article was first published in Partners in Costs Spring 2018